ASH 2022 Update: Aplastic Anemia and PNH
Dr. Emma Groarke discusses research most relevant to patients reported over the past year on the biology and treatment on
IMPORTANT: UPDATED Guidance for Patients on COVID-19 including Vaccine Information»
Dr. Emma Groarke discusses research most relevant to patients reported over the past year on the biology and treatment on
Dr. Tantravahi has received his medical degree from Guntur medical college, India. He then completed Internal Medicine residency and Hematology and Oncology fellowship training at University of Utah Hospital. His clinical interests include multiple myeloma, stem cell transplantation, and myeloproliferative neoplasm. Research interests are targeted therapy in CML and myeloproliferative neoplasms.
Here are the session recordings and the presentations for the 2023 Omaha Patient and Family Hybrid Conference.
AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with
AAMDSIF is pleased to announce that we will host a support group for patients who have undergone transplant for
This virtual support group is designed to support pediatric parents whose children have been diagnosed with
AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with
Alicia Rovó is a Senior Attending/ Deputy Phychian-in-chief and Head of the Clinial Hematology Unit at Bern University Hospital in Switzerland. Her top areas of expertise are
Watch experts Régis Peffault de Latour, Alicia Rovó, and Phillip Scheinberg as they discuss
AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with
